29
/es/
es
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
Crear
Public Timelines
Biblioteca
FAQ
For education
Cabinet
For educational institutions
For teachers
For students/pupils
Descargar
Export
Crear una copia
Insertar en el Sitio Web
editar
Vistas 343
0
0
Tamiflu
Creado
Jasmine
⟶ Actualizado 4 dic 2017 ⟶
List of edits
Comentarios
Eventos
Gilead Sciences announces discovery of orally active influenza inhibitors
Gilead Sciences & Hoffman La-Roche announce worldwide influenza collaboration
Hoffman La-Roche and Gilead Sciences initiate human testing of oral influenza drug GS4104
Phase 2 human testing of oral influenza drug GS4104 begins
Oral influenza compound reduced symptoms and prevented illness in humans
Flu patients in the U.S. may now have access to experimental oral treatments for influenza
Gilead announces preliminary results from phase 2/3 studies
Gilead announces that partner Hoffmann La-Roche disclosed GS4104 phase 3 study results
Hoffman La-Roche submits NDA
First FDA approval of Roche's Tamiflu, a new flu treatment